CIK 0001528115 · Non-accelerated filer<br>Smaller reporting company
Annexon, Inc.
Sign in to watch- Ticker
- ANNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 275414423
- Phone
- (650) 822-5500
- Business address
- 1400 SIERRA POINT PARKWAY, BLDG C, SUITE 200, BRISBANE, CA, 94005
- 8-K Event Other events
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- EFFECT Other Notice of Effectiveness
- POS EX Other Post-effective Amendment
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- SC 13G Stake Amended Statement of Ownership
- 4 Open-market buy President & CEO bought 60,000 shares at $2.45 ($146,814)
- 8-K Event Other events
- POS AM Other Post-effective Amendment for Registration Statement
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Results of operations
- 10-K Report Annual Report
- POSASR Other POSASR
- 8-K Event Other events
- 4 Grant or award President & CEO acquired 40,000 shares (grant or award)
- 4 Grant or award EVP & Chief Business Officer acquired 12,500 shares (grant or award)
- 4 Grant or award EVP & Chief Medical Officer acquired 12,500 shares (grant or award)
Page 19 of 27 · 524 filings